Released Apr 26, 2018, before the open
10-Q filed Apr 26, 2018, 26 days after period end · 0000917520-18-000019
Q1 2018 · 10-Q
Revenue$357.08M$357.08M +38.1% vs Q1 2017−3.1% vs Q4 2017
Net Income$10.99M$10.99M +71.9% vs Q1 2017−75.2% vs Q4 2017
EPS Diluted$0.14$0.14 +75.0% vs Q1 2017−75.0% vs Q4 2017
Gross Profit$212,860,000+23.7%
Operating Income$25,579,000+156.8%
Operating Cash Flow$41,531,000+43.8%
Free Cash Flowderived$26,144,000+32.8%
Margins · derived
Gross margin59.6%−6.9 pt vs Q1 2017
Operating margin7.2%+3.3 pt vs Q1 2017
Net margin3.1%+0.6 pt vs Q1 2017
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|
| Revenue | $357.08M | $258.64M | $236.77M | $202.53M |
| Net Income | $10.99M | $6.39M | $13.42M | $8.38M |
| EPS Diluted | $0.14 | $0.08 | $0.18 | $0.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR